Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients.

导出 OA

翻译打印收藏纠错

作者： Joel M,Michalski ^[1] ; Elizabeth R,Lyden ^[1] ; Andrea J,Lee ^[1] ; Zaid S,Al-Kadhimi ^[1] ; Lori J,Maness ^[1] ; Krishna,Gundabolu ^[1] ; Vijaya Raj,Bhatt ^[1]

作者单位： Department of Internal Medicine, Section of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE, USA. ^[1]

关键词 10-day decitabine acute myeloid leukemia frail patients hypomethylating agents older adults overall survival

主题词老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)

DOI 10.2217/fon-2019-0001

PMID 31170814

发布时间 2020-06-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Future oncology (London, England)

2019年15卷17期

1989-1995页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients.

Future oncology (London, England)

相似文献

Future oncology (London, England)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients.

Future oncology (London, England)

相似文献

Future oncology (London, England)

相关期刊

检索历史清除